GoodRx Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
$GDRX
EDP Services
Technology
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
________________________________________
FORM 8-K
________________________________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): June 3, 2025
________________________________________
(Exact Name of Registrant as Specified in its Charter)
________________________________________
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
2701 Olympic Boulevard | ||
Santa Monica, California | ||
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s Telephone Number, Including Area Code: (855 ) 268-2822
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Class A Common Stock, $0.0001 par value per share |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act
of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the
Exchange Act. ☐
Item 5.07. Submission of Matters to a Vote of Security Holders
On June 3, 2025, GoodRx Holdings, Inc. (the “Company”) held its Annual Meeting of Stockholders. Holders of the
Company’s Class A common stock were entitled to one vote per share held as of the close of business on April 9, 2025 (the
“Record Date”) and holders of the Company’s Class B common stock were entitled to ten votes per share held as of the
Record Date. A total of 89,529,900 shares of the Company’s Class A common stock and 256,869,320 shares of the
Company’s Class B common stock were present in person or represented by proxy at the meeting, representing
approximately 99.5% of the combined voting power of the Company’s Class A and Class B common stock as of the Record
Date. The following are the final voting results for the proposals considered and voted upon at the meeting, each of which
were described in the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on April
23, 2025.
Item 1 — Election of three Class II directors for a term of office expiring on the date of the Annual Meeting of
Stockholders to be held in 2028 and until their respective successors have been duly elected and qualified or until their
respective earlier death, resignation or removal.
Votes FOR | Votes WITHHELD | Broker Non-Votes | |
Christopher Adams | 2,601,325,292 | 17,792,259 | 39,105,549 |
Trevor Bezdek | 2,605,031,761 | 14,085,790 | 39,105,549 |
Scott Wagner | 2,603,777,388 | 15,340,163 | 39,105,549 |
Item 2 — Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered
public accounting firm for the fiscal year ending December 31, 2025.
Votes FOR | Votes AGAINST | Votes ABSTAINED | Broker Non-Votes |
2,656,638,262 | 535,559 | 1,049,279 | 0 |
Item 3 — Approval, on an advisory (non-binding) basis, of the compensation of the Company’s named executive
officers.
Votes FOR | Votes AGAINST | Votes ABSTAINED | Broker Non-Votes |
2,617,157,377 | 1,705,462 | 254,712 | 39,105,549 |
Based on the foregoing votes, the Company’s stockholders (i) elected Christopher Adams, Trevor Bezdek and Scott
Wagner as Class II directors; (ii) ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent
registered public accounting firm for the fiscal year ending December 31, 2025; and (iii) approved, on an advisory (non-
binding) basis, the compensation of the Company’s named executive officers.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report
to be signed on its behalf by the undersigned hereunto duly authorized.
GOODRX HOLDINGS, INC. | |||
Date: | June 4, 2025 | By: | /s/ Christopher McGinnis |
Name: Christopher McGinnis Title: Chief Financial Officer & Treasurer |